IQuity Lands NIH Grant To Help Identify Alzheimer's Early
Executive Summary
The $320k grant will support research that builds on IQuity’s autoimmune diagnostic expertise and new data analytics platform. The company believes the emerging therapies for Alzheimer's will be most effective if they are used to treat the disease early in its progression.